Average weight loss on semaglutide 2.4 mg weekly, from STEP 1 (Wilding et al. 2021, NEJM): about 3-4% at week 12, 8-10% at week 28, 13-14% at week 52, and 14.9% at week 68. That’s the mean trajectory from a 68-week placebo-controlled trial of 1,961 adults with overweight or obesity.<\/p>\n
Individual results vary widely. About 86% of STEP 1 participants on 2.4 mg lost at least 5% of body weight, 69% lost 10% or more, 51% lost 15% or more, and 32% lost 20% or more. The placebo group averaged 2.4% loss over the same 68 weeks.<\/p>\n
This article maps out what each phase looks like on the scale, what changes in appetite and energy, and the factors that put someone above or below the average curve.<\/p>\n
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.<\/p>\n
The starter dose (0.25 mg weekly) is sub-therapeutic for weight loss.<\/strong> Average loss in weeks 1-4 is 1-3 pounds, often just water shift as glycogen and inflammation drop. Some people see no movement on the scale at all in month one.<\/p>\n Quick Answer: STEP 1 average weight loss: 14.9% of body weight at 68 weeks on 2.4 mg semaglutide<\/p>\n What you do notice is appetite changes. Within 2-3 days of the first injection, snack cravings ease and meals end faster. Many users describe it as “food noise quieting.” Energy and sleep often shift in this window too, sometimes for better, sometimes worse as the body adjusts.<\/p>\n Bottom line for month one: don’t judge the drug by the scale yet. The dose is intentionally low to build tolerance. Real weight loss begins once titration crosses 0.5 mg in week 5.<\/p>\n The 0.5 mg dose starts producing measurable weight loss.<\/strong> Average loss in STEP 1 through week 8 was about 3-4% of body weight, which is roughly 6-9 pounds for someone starting at 220. Weekly drops of 1-2 pounds become typical.<\/p>\n Appetite suppression deepens. People often report eating half their previous portions without effort. The first wave of obvious clothing-fit changes usually shows up around week 6-8 even if the scale moves slowly. Waist measurements tend to drop faster than weight because visceral fat goes first.<\/p>\n Side effects from the dose increase are normal in days 1-7 of week 5. Nausea, fatigue, and digestive shifts usually resolve by day 10. If they don’t, this is when many people pause titration and hold at 0.5 mg longer.<\/p>\n Weeks 9-12 on 1.0 mg are usually the fastest weight-loss phase.<\/strong> Average loss accelerates to 5-8% of body weight by week 12, or 11-18 pounds from 220. The curve is steepest here because the drug is at a fully therapeutic level and the body hasn’t yet adapted.<\/p>\n Weeks 13-16 on 1.7 mg often shows another small acceleration. By week 16, STEP 1 averages reached about 10% of body weight, around 22 pounds from a 220-pound start. This is also where many people first hit measurable health improvements: lower fasting glucose, lower blood pressure, less joint pain, better sleep.<\/p>\n Some people choose to hold at 1.7 mg rather than escalate. If you’re losing 1-2 pounds per week and tolerating the dose well, holding is often the best move. The 2.4 mg maximum isn’t required for everyone.<\/p>\n Once on 2.4 mg (or your maintenance dose), the rate of loss slows but doesn’t stop.<\/strong> STEP 1 averages went from 10% at week 16 to about 13-14% by week 28. That’s roughly 1 pound per week.<\/p>\n This is the phase where adherence and habits matter most. The drug suppresses appetite, but protein intake, strength training, sleep, and stress all influence whether the energy deficit translates to fat loss or muscle loss. Aim for 1.2-1.6 g protein per kg body weight per day and 2-3 resistance training sessions weekly.<\/p>\n Many people start seeing the second wave of visible change here. Face shape changes, jawline definition returns, and clothing sizes drop. Body composition (DEXA scan or smart scale) shows fat percentage dropping while lean mass holds, when nutrition and training are in line.<\/p>\n Average STEP 1 loss reached 13-14% by week 52.<\/strong> The rate slows to about 0.3-0.5 pounds per week through this phase. Some people experience their first true plateau at month 9-10 where the scale doesn’t move for 3-4 weeks at a time.<\/p>\n Plateaus are biologically normal. The body’s resting metabolic rate falls as weight drops because there’s less mass to maintain. Hormonal adaptations including reduced leptin and increased ghrelin sensitivity also occur. Pushing through a plateau usually means a dose review, a hard look at intake and protein, and sometimes a brief diet break to reset.<\/p>\n By month 12 on the average trajectory, someone starting at 220 pounds has lost about 28-31 pounds. Clinically that’s enough to push down BMI category, improve sleep apnea, and reverse or substantially improve prediabetes.<\/p>\n STEP 5 (Garvey et al.<\/strong> 2022, Nature Medicine) followed 304 people for 104 weeks on semaglutide 2.4 mg and showed continued weight loss past 68 weeks. Average loss at week 104 was 15.2%, only slightly more than the 14.9% at 68 weeks. The plateau is real.<\/p>\n In practical terms, year 2 is maintenance with small additional losses if you’re still pursuing them. Most weight comes off in year 1. Year 2 is about consolidating habits, refining body composition, and finding the lowest effective maintenance dose.<\/p>\n This is also when many people start exploring lower doses or alternate-week dosing under provider supervision. There’s no strong evidence base for tapering protocols, but clinical practice has moved toward “lowest effective dose” rather than maximum lifetime.<\/p>\n The biggest predictor is dose adherence and titration completion.<\/strong> People who reach 2.4 mg and stay there lose more than those who hold at lower doses. The second predictor is protein intake. STEP 1 subgroup analyses showed people in the top quartile of protein consumption lost about 2-3% more fat (and less muscle) than the bottom quartile.<\/p>\n Resistance training matters. People who lift weights 2-3x weekly preserve more lean mass and end up with better body composition at the same weight. Sleep under 7 hours per night reliably slows weight loss by 15-20% across multiple obesity trials.<\/p>\n Genetics, baseline insulin resistance, and gut microbiome differences also matter but aren’t easily modifiable. Women in the perimenopausal window may lose slightly slower due to hormonal shifts. Men typically lose faster initially but plateau at similar relative percentages.<\/p>\n Key Takeaway: Weight loss accelerates from week 8-12 once titration reaches therapeutic doses<\/p>\n About 14% of STEP 1 participants on 2.4 mg failed to reach the 5% weight loss threshold.<\/strong> The most common reasons are inadequate dose, insufficient time on the maximum dose, food intake that hasn’t dropped despite reduced appetite, and conditions like untreated hypothyroidism or PCOS that need separate management.<\/p>\n Action steps if the scale isn’t moving after 12 weeks on 2.4 mg: log food intake for a week to verify the deficit is real, check thyroid function (TSH) and other hormones, review sleep and stress, and discuss switching to tirzepatide. SURMOUNT-1 (Jastreboff 2022, NEJM) showed 20.9% average loss on tirzepatide at 72 weeks, with higher response rates in semaglutide non-responders.<\/p>\n TrimRx providers review progress at regular intervals as part of the personalized treatment plan. If your trajectory is well below average, the plan can adjust before the issue becomes a longer-term stall.<\/p>\n STEP 4 (Rubino 2021, JAMA) randomized 803 people who had completed 20 weeks of semaglutide titration to continue 2.4 mg or switch to placebo.<\/strong> The continuation group lost another 7.9% over the next 48 weeks. The placebo group regained 6.9%.<\/p>\n That regain pattern, about two-thirds back over the year after stopping, is consistent with what happens after most weight-loss interventions including bariatric surgery and lifestyle programs. The drug suppresses appetite, and when it leaves the system, appetite returns.<\/p>\n This is why obesity is treated as a chronic relapsing condition and why most clinical guidance now favors long-term GLP-1 use rather than short courses. Some people maintain after stopping if they’ve built strong habits, but the majority will regain. Planning for long-term maintenance from day one is more realistic than planning to “finish” treatment.<\/p>\n Total weight loss in STEP 1 averaged 14.9% at week 68 on the 2.4 mg dose.<\/strong> Body composition analysis from a subset of participants showed roughly 60% of the weight loss came from fat mass and 40% from lean mass. This ratio matters because too much lean mass loss accelerates sarcopenia, especially in older adults.<\/p>\n The lean mass component included some muscle, some bone density, some water, and some glycogen. The true “muscle loss” portion is hard to pin down with standard DEXA but is generally estimated at 20-30% of total weight lost.<\/p>\n This is why protein intake (1.2-1.6 g\/kg\/day), resistance training (2-3 sessions\/week), and adequate sleep matter throughout treatment. Participants in the top quartile of protein consumption in STEP 1 retrospective analyses lost less muscle and ended up with better metabolic outcomes.<\/p>\n Visceral fat (the deep abdominal fat surrounding organs) drops faster than subcutaneous fat on semaglutide.<\/strong> MRI studies show 20-30% reductions in visceral adipose tissue at 28-52 weeks, which is disproportionate to total weight loss.<\/p>\n This is why waist measurements often improve faster than weight on the scale. Visceral fat is the more metabolically harmful fat depot, so its preferential loss explains why metabolic improvements (insulin sensitivity, blood pressure, lipids) often outpace what weight loss alone would predict.<\/p>\n The pattern is similar to bariatric surgery and other significant weight-loss interventions: visceral fat goes first, subcutaneous fat goes more slowly.<\/p>\n After reaching goal weight, daily life on semaglutide maintenance is largely unremarkable.<\/strong> Appetite is still suppressed but less dramatically than during active weight loss. Meals are smaller. Snacking is rare. Energy is steady when nutrition is adequate.<\/p>\n Most patients describe a settled relationship with food after the first year. The “food noise” that dominated pre-treatment thinking remains quieter. Special occasions, vacations, and celebratory meals are tolerated normally; rebound binges are uncommon.<\/p>\n The medication continues to suppress appetite as long as it’s in the system. Stopping triggers appetite return within 2-4 weeks, which is why long-term maintenance is the standard approach.<\/p>\n Bottom line: Stopping the drug leads to about two-thirds regain over 12 months (STEP 4)<\/p>\n Most people lose 2-4 pounds in month one. Some lose none. The starter dose is below the therapeutic range, so the first real weight loss phase begins in month two when titration reaches 0.5 mg.<\/p>\n Yes. Weight plateaus of 2-4 weeks are normal at any point in the trajectory. They reflect water shifts, metabolic adaptation, and body composition changes that don’t show on the scale. Trends over 8-12 weeks matter more than week-to-week numbers.<\/p>\n STEP 1 trial participants got intensive lifestyle support including monthly counseling, food logs, and structured exercise plans alongside the drug. Real-world loss tends to run 70-80% of trial averages without that support. Other factors include insulin resistance, sleep, age, and dose escalation pace.<\/p>\n True permanent plateaus typically appear around week 52-68 on a stable dose. Earlier plateaus usually break with dose adjustment, intake review, or addressing sleep and stress.<\/p>\n About two-thirds of lost weight, on average, comes back within 12 months of stopping (STEP 4 data). Building habits during treatment helps, but the underlying biology that drove weight gain doesn’t disappear.<\/p>\n Some, but not as much. Appetite suppression naturally cuts calories for most people, but if you eat the same volume of highly processed, sugar-dense foods, results will fall well below the STEP 1 averages. Higher protein and lower processed food make a measurable difference.<\/p>\n Yes. Loss of lean mass during weight loss accelerates sarcopenia, especially over age 50. Aim for 1.2-1.6 g protein per kg per day and 2-3 resistance training sessions weekly to preserve muscle. DEXA scans before and during treatment can track body composition.<\/p>\n Disclaimer:<\/strong> This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.<\/p>\n <\/p>\n Average weight loss on semaglutide 2.4 mg weekly, from STEP 1 (Wilding et al.<\/p>\n","protected":false},"author":11,"featured_media":92692,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"Compounded Semaglutide Real Results: Weight Loss Timeline & What Patients Report","_yoast_wpseo_metadesc":"Average weight loss on semaglutide 2.4 mg weekly, from STEP 1 (Wilding et al.","_yoast_wpseo_focuskw":"compounded semaglutide results","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[7],"tags":[22,42,46,56],"class_list":["post-89327","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-semaglutide","tag-compounded","tag-results","tag-semaglutide","tag-weight-loss"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=89327"}],"version-history":[{"count":4,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89327\/revisions"}],"predecessor-version":[{"id":93693,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89327\/revisions\/93693"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/92692"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=89327"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=89327"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=89327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}What Does Month 2 (Weeks 5-8) Look Like?<\/h2>\n
What About Months 3-4 (Weeks 9-16)?<\/h2>\n
What Happens at Months 5-8 (Weeks 17-32)?<\/h2>\n
What About Months 9-12 (Weeks 33-52)?<\/h2>\n
What Does the Second Year Look Like?<\/h2>\n
What Predicts Faster or Slower Results?<\/h2>\n
What If You’re Not Losing Weight?<\/h2>\n
What Happens When You Stop?<\/h2>\n
What Does the Body Composition Story Look Like?<\/h2>\n
What About Visceral Fat Specifically?<\/h2>\n
What Does Life Look Like at Maintenance?<\/h2>\n
FAQ<\/h2>\n
How Fast Should I Expect to Lose Weight in the First Month?<\/h3>\n
Is It Normal to Lose Nothing for 2-3 Weeks?<\/h3>\n
Why Am I Losing Slower Than the STEP 1 Average?<\/h3>\n
When Do I Plateau Permanently on Semaglutide?<\/h3>\n
How Much of the Weight Comes Back If I Stop?<\/h3>\n
Can I Lose Weight on Semaglutide Without Changing What I Eat?<\/h3>\n
Does Muscle Loss Matter at My Age?<\/h3>\n
Related Articles<\/h2>\n
\n